Lawrence Otto Klein
President, CEO & DirectorDr. Lawrence Otto Klein, Ph.D, is an Independent Director of Jade Biosciences, Inc. since July 2024. Dr. Klein is Chief Executive Officer of Oruka Therapeutics and serves as its Director. Dr. Klein served as Partner of Versant Venture Management, LLC since joining from January 2023 to February 2024. He served as an Independent Director at Dyne Therapeutics, Inc. since September 2019 until May 2023. Dr. Klein served as Chief Operating Officer at CRISPR Therapeutics AG since January 26, 2020 until December 2022. Dr. Klein served in various positions at CRISPR Therapeutics AG, a biotechnology company, including Chief Business Officer since January 2, 2019 until January 25, 2020, Senior Vice President, Business Development and Strategy from November 2017 to December 2018 and as Vice President of Strategy from February 2016 to November 2017. He has scientific background and has business development and operational experience as a senior executive in the biotechnology industry. Dr. Klein served as Vice President of Corporate Development at CRISPR, where he led the formation of a number of strategic collaborations and was a key contributor in developing the company’s initial corporate strategy. Before joining CRISPR, he was an Associate Partner at McKinsey & Company from October 2014 to February 2016 and was a leader in the biotech practice. He served as an Independent Director of Jasper Therapeutics, Inc. since September 2021 until June 20, 2023. He served a number of biotechnology companies on a wide range of topics from strategy to operations. He received his Ph.D. in Biophysics from Stanford University where he conducted research in the field of T-cell immunology that led to several publications in leading scientific journals. Dr. Klein obtained a B.S. in Biochemistry and Physics from the University of Wisconsin-Madison and his Ph.D. in biophysics from Stanford University.
Positions
- Company NameOruka Therapeutics, Inc.Stock CodeORKAPositionPresident, CEO & DirectorColleagues
- SKSamarth KulkarniIndependent Chairman of Board
- PTPaul T. QuinlanGeneral Counsel & Secretary
- JGJoana GoncalvesChief Medical Officer
- AAArjun AgarwalSenior VP of Finance & Treasurer
- LSLaura SandlerChief Operating Officer
- KMKristine M. BallIndependent Director
- PEPeter Evan HarwinIndependent Director
- ABAndrew BlauveltChairman of Scientific Advisory Board
- Company NameJade Biosciences, Inc.Stock CodeJBIOPositionIndependent DirectorColleagues
- TFTom FrohlichPresident, CEO & Director
- ELEric L. DobmeierIndependent Chairman
- BDBradford D. DahmsCFO and Chief Business Officer
- AJAndrew James KingPresident of Research & Development
- EBElizabeth BaltaChief Legal Officer & Corporate Secretary
- LSLori StewartSenior Vice President of People
- TKTomas KiselakIndependent Director
- LOLawrence Otto KleinIndependent Director
- EMErin M. LavelleIndependent Director
